Teladoc Health Investor Presentation — September 2020

Document content

Transforming Healthcare,

Across the Continuum

Creates the global leader in virtual care across primary, ambulatory, acute, complex

Positions combined company to lead the market and set the pace for a rapidly evolving

Establishes a consumer -centric, whole -person virtual care solution, driving better

care for consumers at a lower cost

Combines two leading high -growth companies built for scale that have

complementary cultures, are led by an experienced management team, and have a

robust integration plan

Delivers significant financial benefits and value creation for shareholders through

clearly identifiable $500 million in run -rate revenue synergies by 2025 and $60 million in

run-rate cost synergies by 2022

Teladoc Health Annual Revenue (in Millions)

guidance)New Clinical

IPO Year2016 2017 2018 Future 2019 2020E Teladoc Health

2015 –2020Since the 2015 IPO, Teladoc Health Has Invested $2B Acquiring Companies and Launched

Dozens of Products and Partnerships

Client Retention Rate

Cost Savings to Client

U.S. Paid Membership203%

Distribution Channel

New International Markets

IPO 2015DermatologyHospital &

Health SystemText-based

2017CaregiverExpert Medical

InternationalDTC PartnerMental Health

Health AssistantPediatrics

MedicaidNutritionLab TestingVirtual Primary

TelemedicineMedicare

2016Broker/SMB MarketB2B

Preview truncated — download the full document for the complete content.